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Serological study of cell membrane antigens in the mouse has revealed several 
isoanfigenic  systems  demonstrable  by  cytotoxic  isoantisera.  Four  of  these 
systems of antigens  are  exclusively or predominantly represented on thymo- 
cytes. One of these, TL  (thymus-leukemia)  (1),  is  exclusively represented on 
thymocytes: two (Ly-A and Ly-B) have predominant representation on thymo- 
cytes and are present also on lymphocytes, but not on any other cell type (ref- 
erence 2  and unpublished data1);  another,  designated 0  (3), also is predomi- 
nantly represented on thymocytes and in lower concentration on lymphocytes, 
but is found in at least one other tissue---adult brain. The major histocompati- 
bility isoantigen of the mouse, H-2, also is demonstrable on thymocytes by the 
cytotoxic test, but in contrast to the first four systems (TL, Ly-A, Ly-B, and 0), 
H-2 is represented poorly on thymocytes in comparison with lymphocytes and 
some other tissues. 
Of these five systems, TL has particular importance in tumor immunology 
because of its appearance in leukemias of strains that do not have the antigen on 
their normal thymocytes. In normal mice TL has the properties of an organ- 
specific isoantigen.  Mice of TL+  strains cannot form TL antibody but mice 
of TL-  strains can do so. TL+  leukemias, however, occur not only in TL+ 
strains but also in TL-  strains. The conclusion is that all strains have a structural 
gene for TL synthesis, but that phenotypic expression on normal thymocytes is 
restricted to TL+  strains.  In  relation to TL there evidently are  two  conse- 
quences of leukemogenesis. First, in TL-  strains the mechanism repressing TL 
synthesis is modified so that the TL character is now expressed. Secondly, in 
* Supported in part by Grants CA 06338 and CA 08748 from the National Cancer Institute, 
National Institutes of Health, United States Public Health Service,  and a grant from the ~[ohn 
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1Ly-A  and  Ly-B  are  tentative  designations for  these two  systems of  isoantigens. 
(Ly, lymphocyte).  Previously  when less  was known about them, the designation  TSL (thymus- 
spleen-lymphocytes)  was suggested (2) but this now appears unsuitable. 
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TL+  leukemias of both TL+ and TL-- strains, expression of the antigen is no 
longer dependent upon the thymic environment so that  TL+  leukemia cells 
appear throughout the body. 
The TL locus is complex and determines three antigenic specificities, TL. 1, 
2, 3. Mice have one of three phenotypes: TL-  ; TL+  (TL. 2); and TL+  (TL. 
1, 2, 3). Only the TL. 1 component is known to appear anomalously in strains 
that normally do not express it; thus TL+  leukemia cells have the phenotype 
TL. 1, TL. 1, 2 or TL. 1, 2, 3 according to the TL type of the strains in which 
they arise. In TL-  strains and in TL+  (TL. 2) strains, TL. 1 must be regarded 
as a leukemia-specific antigen. 
Genetic studies have shown that  the locus determining the TL antigens is 
closely linked to H-2 and adjacent to the "D end" of thislocus (4). Furthermore, 
the quantity of H-2  antigen in thymocytes is related to the presence or ab- 
sence of TL antigen; TL+  thymocytes have less H-2 antigen than TL-- thy- 
mocytes (3). This observation suggested the possibility of some relationship at 
the chemical level between H-2 and TL antigens. 
Recent studies of H-2 isoantigens have revealed that these substances can be 
solubilized and  purified to a  point  at  least  approaching homogeneity (6,  7). 
During  the process of H-2 purification it has been shown that  all of several 
non-H-2 specificities that were tested for are lost; indeed, many non-H-2 anti- 
gens appear to have properties distinguishing them as a group from H-2 antigens 
(8).  Initial  experiments showed that  when H-2  antigens were extracted from 
TL+  leukemia cells TL specificity could be detected in  the soluble material 
carrying H-2 activity. This encouraging finding led to the experiments described 
in this paper where it will  be shown that TL antigens  can be extracted and 
purified by the methods that have been used in chemical studies of H-2 antigens. 
Evidence has been given (7) that at least some of the several specificities deter- 
mined by the H-2 allele of a  particular mouse strain are carried on the same 
molecule. The possibility was entertained that the TL antigenic determinants 
also would be found on the H-2 molecule. But this proves not to be the case; as 
we report here, TL soluble antigen can be separated from H-2 soluble antigen 
by column chromatography. 
Materials and Methods 
Mice and  Leukemias.--The following mouse stocks were used:  A  (H-2  a,  TL.  1,  2, 
3), C57BL/6 (H-2  b, TL--), 129 (H-2  b, TL. 2) BALB/c (H-2  d, TL. 2), H-2H (H-2h), H-2I 
(H-2  i) C3H/An (H-2k), (C57BL X  A)  Fa,  (BALB/c X  C3H/An) F1, and  C57BL/TL+ 
(H-2 b, TL. 1, 2, 3). The C57BL/TL+ stock originated from a female of the cross-over  pheno- 
type H-2b: TL+ from  a backcross of strain A (H-2a: TL+) to C57BL/6 (H-2b: TL--) (2). 
A serial backcross to C57BL/6 was initiated with this female. TL++ homozygotes  were ob- 
tained by crossing heterozygous  TL+ -- progeny of the eighth backcross. These homozygotes 
were inbred to produce the C57BL/TL+ stock which is congenic  with C57BL/6, differing 
only at the TL locus (except  for the effects  of unrecognized  residual heterozygosity). 
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(C57BL/6 radiation-induced leukemia D) are described elsewhere (1). Ascites leukemia EIA 
(TL--)was carried in C57BL/6 mice. 
Cytotoxi¢ T~t Systems.--The activity of H-2 and TL preparations was measured by their 
capacity to inhibit the lysis of target cells exposed to isoantibody and guinea pig complement. 
The various antisera used and the specifidties  which they detect are indicated in Table I. The 
criterion of lysis employed in the studies reported here was mainly that of failure to exclude 
trypan blue, but release of radioactive label (chromium-51  chromate) was used in cytotoxic 
tests to scan column eluates for specific  inhibitory activity, as previously described (6-8). 
TABLE  1 
Cytotoxic Test Systems for TL, H-2, O, and Ly-B Specificities 
Mouse strain 
immunized 
',STBL/6 
BALB/c X 
C3H/An)FI 
'.3H 
;ALB/c 
lrR 
C3H/An X I)F1 
Cells 
injected 
Strain A leuke- 
mla ASL1 
(H-2S: TL. 1, 
2, 3) 
129 thymocyte~ 
Leukemia ASLl 
A (spleen) 
A (spleen) 
Leukemia 
EIA/C57BL 
C3H thymocytes 
Leukemia 
EL4/C57BL 
Antibodies 
present 
"eL, 1, 2, 3 
H-2.1, 3, 4, 8, 
10, 11, 13 
TL. 2 
TL. 1,3 
H-2.4,  10, 13 
H-2.1,  5, 11 
]]-2.2,  22, 33 
0CSH 
Ly-B.2  (and 
H-2) 
Absorption 
129 spleen  ceils 
In vivo in (C57BL 
X A)FI 
mice carrying 
leukemia ERLD 
Target ceil 
*C57BL/TL+ 
thymocytes 
Leukemia ERLD 
(C57BL/6) 
H-2H lymph  node 
cells 
H-2I lymph node 
cells 
129 thymocytes 
A thymocytes 
BALB/c lymph 
node cells 
C3H lymph node 
cells 
EIA leukemia 
ceils (C57BL) 
C3H thymocytes 
C57BR 
thymocytes 
Specificifies 
detected 
TL.  1, 2, 3 
TL. 1 
H-2 ("K region") 
CH-2.1, 3, 8, 11) 
H-2 ("D region") 
(H-2.3, 4, 13) 
TL. 2 
TL. 3 
H-2.4, 10, 13 
H-2.1, 5, 11 
H-2.2, 22, 33 
0C3H 
Ly-B.2 
* Congenle  with C57BL/6, differing  at TL locus (see text). 
Cytotoxic tests with trypan blue were set up in the form of titrations of antigen in the pres- 
ence  of  a  constant  volume  of  antiserum  previously  diluted  to  the  region  of  the  end 
point (<90% lysis of target cells exposed to antibody in the absence of antigen). Each tube 
contained antigen (0.025 ml), antibody (0.025 ml), cell  suspension (5  X  106/mi;  0.05  nil), 
guinea pig serum (absorbed with mouse ceils in the cold to remove natural antibody; diluted 
1/3; 0.05 ml). The constituents of the test were added in the order stated, the tubes being im- 
mersed in an ice bath. After incubation for 45 rain at 37°C in a water bath, with repeated shak- 
ing, the racks were transferred to an ice bath and counts of viability were performed in the 
presence of trypan blue (prepared as a  stock solution in distilled water and brought to iso- 
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included titration of antigen in a  "reciprocal" serum, (e.g. antigen from an H-2  a source tested 
with serum H-g  a anti-tt-2~); in no instance was inhibition observed, excluding the possibility 
of nonspecific  inhibition from such effects as anticomplementary activity. 
Preparagon of Antigen.--This was performed as previously described in detail (8)  except 
that whereas 0.7% NaC1 had been used to extract normal lymphoid cells, the NaC1 concentra- 
tion was lowered to 0.3% to extract ASL1 leukemic cells because they are less fragile. 
Crude lipoprotein "eluate"  from 150 (C57BL X  A)FI hybrid spleens of mice that had been 
inoculated 7 days previously with ASL1 cells was prepared by repeated hypotonic salt extrac- 
tion but not to the point of cell rupture.  These cell-free extracts were pooled, centrifuged at 
55,000 g, and the sediment suspended in water at 10 mg/ml and kept at +2°C with thymol as 
preservative. The 150 spleens weighed 108 g (approximately 20 g dry weight) and the yield of 
1'0 
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FIG. 1.  Ehition pattern  of crude solubilized  H-2 antigen, isolated from ASL1  (H-2a)  leu- 
kemic cells, on P300 Bio-Gel gel filtration. 280 m/z-absorbance shows the background protein 
pattern. •  •,  H-2 specific activity measured by inhibition of cytotoxicity in the system 
H-2.1, 5, 11 plotted on an arbitrary scale; truncation of the peak is due to samples giving maxi- 
mum inhibition at the sensitivity used. Fractions retained: H-2 active, 30-50 ml; high molecu- 
lar size fraction (HMW), 10-29 ml: and low molecular size fraction (LMW), 51-80 ml. 
lipoprotein was  1.35 g  (dry weight). This material reacted strongly not only for H-2  (H-2  a) 
specificity but also in tests for TL specific activity. 
Solubilization was carried out by the procedure described for H-2 antigen (6), in the knowl- 
edge derived from preliminary experiments indicating that TL had become sohibilized  under 
conditions of H-2 release from lipoprotein. Procedures were monitored by following H-2  ac- 
tivity using the systems H-2.4, 10, 13 and H-2.1, 5,  11. Lipoprotein (1.2 g) at  10 mg/ml was 
made 0.05 ~  with respect to tris buffer at pH 7.4 and incubated at 37°C for 2.5 hr. The sus- 
pension was cooled in ice and centrifuged in the cold at 105,000 g for 2 hr; the sediment was 
stored for further use and the supernatant  dialyzed and freeze dried, giving 144 mg of crude 
soluble material. 
EXPERIMENTAL RESULTS 
Use of P300 Bio-Gel.--Crude  soluble antigen (120 mg) was divided into three 
parts  (40 mg each) and each part run through a  P300 Bio-Gel column (Bio-Rad D.  A.  L. DAVIES,  E.  A. BOYSE,  L. J. OLD~  E.  STOCKERT  553 
Laboratories, Richmond, Calif.) measuring  1 X  20 cm. The pattern in each case 
was essentially that previously recorded for H-2 fractionations (7) and is shown 
in Fig. 1. Tests for H-2 antigen showed activity in the region of 30-50 ml of the 
coh]mn  eluate and three pools were made: the higher  molecular  size fraction 
("HMW", 10-29 ml), the H-2 active fraction (30-50 ml), and the lower molecu- 
lar size fraction ("LMW", 51-80 ml). These were dialyzed and freeze dried to 
give HMW, 30 mg; H-2 active, 62 rag; and LMW,  15 rag.  When  tested for 
ability to give specific inhibition in the TL. 1, 2, 3 combined system the higher 
and lower molecular size fractions that had no H-2 activity gave totally nega- 
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FzG. 2.  Cytotoxic inhibition tests on DEAE Sephadex fractions A, B, and C in the systems 
representing specificities determined by opposite ends (D and K) of the H-2 locus. C)-  C), 
A  (K);  Q,  O,  A  (D);  A  A,  B  (K); •  ....  •,  B  (D);  []  [],  C  (K); 
~----~,  C (D). In both D and K systems fraction B gives 50~ inhibition  at approximately 
80 btg/ml, fractions A and C give no measurable inhibition at the highest level tested (1 rag/ 
ml final concentration in test mixture). 
tive results; the H-2 active fraction, however, was a potent inhibitor in the TL 
system. 
Use of DEAE Sephadex.--The  active fraction recovered from the P300 Bio- 
Gel  columns,  which served to remove inactive materials  of higher  and lower 
molecular weight, was dissolved (60 rag) in 5 ml of 0.1 ~r tris buffer and dialyzed 
overnight against 1 liter of the same buffer for equilibration. The solution was 
placed on a column of DEAE Sephadex A50 (Pharmacia Fine Chemicals  Inc., 
Uppsala,  Sweden)  and eluted with a  salt gradient  (NaC1)  from 0.1  to 0.4 ~, 
the volume being 750 ml. The 280 m/~ absorbance pattern showed three major 
components,  as had  previously been described in H-2  antigen  fractionations 
(7). The column eluate tubes were scanned for H-2 specific inhibitory activity 
in the cytotoxic test with the system H-2. 1, 5, 11 and activity was found in the 
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one for each of the three major protein peaks, giving fraction A  (22 mg), frac- 
tion B (H-2 active, 20 rag), and fraction C (16 rag). 
The  relative potency of the  three fractions,  A  (eluted at  low molarity),  B 
(eluted at intermediate molarity), and C (eluted at higher molarity) was tested 
in the systems H-2.  1, 5,  11 and H-2.4,  10,  13 and negligible activity was re- 
corded for fractions A and C. Similar tests were made for the "D end" and the 
"K end" of the H-2 locus (systems H-2.1, 3, 8, 11 and H-2.3, 4, 13 respectively) 
with similar results, as shown in Fig. 2. The correct H-2 specificity of the prod- 
uct  (ASL1  cells are  of A strain origin) indicated by these  reactions for H-2.1, 
o~,  ¢~-  .......  ~ 
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FIG. 3.  Cytotoxic inhibition tests on DEAE Sephadex fractions A, B, and C in the system 
TL.1, 2, 3: fraction A, O  O; fraction B, Zk  Zk; fraction C, []  D. 500/0 of 
maximum inhibition fraction A, inactive at  1 mg/ml; fraction B, 230/~g/ml; fraction C, 60 
~g/ml. 
3, 4, 5, 8,  10,  11,  13 was confirmed by failure to obtain any inhibition  in the 
system H-2.2, 22, 33 (see Table I) with the active B fraction. 
Tests on fractions A, B, and C for specific inhibitory activity in the TL sys- 
tems showed a  consistently different pattern.  A  TL.1,  2,  3  test illustrated  in 
Fig. 3 shows that  fraction  C  carried most of the activity, with some overlap 
into the H-2-active B fractions; fraction A gave a slight effect barely measur- 
able at maximum concentration at the 50 % inhibition level. Individual tests on 
the three fractions for TL.  1, TL.  2, and TL.  3  gave a  consistent pattern  as 
shown in the tests illustrated in Figs. 4 a-4 c; ignoring the effect of fraction A, 
not measurable in any instance at the 50 % level, the following figures were ob- 
tained for the relative activities expressed as B/C: TL. 1, 2, 3--1/4; TL. 1--1/5; 
TL. 2--1/2.3; TL. 3--1/5. 
Tests for other mouse isoantigens in fractions A, B, and C showed no reac- 
tivity for 0-C3H (3), in accordance with previous evidence that this antigen is 
destroyed during solubilization procedure (7), and none for Ly-B2. 100 I-"  O 
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I~GS. 4 a--4 c. Cytotoxic inhibition tests  on DEAE Sephadex fractions A (O  O), 
B (A  Lk), and C (n  [~) in TL systems. 
Fro. 4 a.  System TL.t (see Table I for definition), 50% inhibition for fraction A, not meas- 
urable; fraction B, 500 #g/ml; fraction C, 100 #g/ml. 
FIG. 4 b. System TL.2,  50% inhibition for fraction A,  1 mg/ml; fraction B,  70 #g/ml; 
fraction C, 30 #g/ml. 
Fio. 4 c.  System TL.3,  50% inhibition for fraction A, not measurable; fraction B, 300 
#g/ml; fraction C, 60 #g/ml. 
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DISCUSSION 
The hypothesis tested in  these  experiments was  that  because of the  close 
linkage of the TL (thymus-leukemia)  and H-2  (histocompatlbility-2) genetic 
determinants (4) there might be some relationship at the chemical level between 
the products of these genes. A functional relationship was suggested also by the 
finding that the quantity of H-2 antigen in thymocytes is reduced by the pres- 
ence  of TL antigens (5), as if there were competition for a defined number of 
sites at the cell surface. It seems clear from the data reported here that there is 
indeed such a chemical relationship, the precise nature of which awaits identifi- 
cation of the chemical structure of the soluble H-2 and TL products. 
The lipoprotein starting material used in H-2 studies is essentially insoluble 
and contains not only H-2 antigen but all of a variety of non-H-2 antigens for 
which tests have been performed (8). As anticipated, TL specificity also was 
present in lipoprotein prepared from a  TL+  source. On solubilization of H-2 
antigen from lipoprotein by the autolytic procedure non-H-2 antigens sought 
thus far are not solubilized (7) although this may not be true of all. In the pres- 
ent  study 0-C3H was shown not to be solubilized. Thus we may be justified in 
attaching significance to the finding that TL is solubilized with H-2. The effi- 
ciency of H-2 solubilization is low and that of TL has not yet been investigated. 
However, although the test systems are not strictly comparable because of their 
different sensitivities  there  are  indications  that  the  absolute  values  for con- 
centration of material giving 50 % inhibition are of the same order for H-2 and 
TL. 
The fraction of intermediate molecular size that was separated on P300 Bio-Gel 
columns contained all the H-2 activity and also all the TL activity, the frac- 
tions of higher and lower molecular size being inactive in tests for both types of 
antigens. It has previously been shown that several specificities determined by a 
particular mouse H-2 allele are present on the same molecule (7), but the possi- 
bility that TL determinants also may be situated on the same molecule as H-2 
is now ruled out in the light of the results from DEAE fractionation of the active 
fraction recovered from P300 Bio-Gel. Three main 280 m/z absorbing  fractions 
were separated from DEAE  columns.  The middle fraction (B)  contained es- 
sentially all the H-2 activity; tests for most of the specificities determined by 
the H-2  ~ allele indicated no obvious deficiences. 
Tests for TL specificities all showed activity located predominantly in frac- 
tion C and overlapping fraction B to some extent. It must be concluded that the 
TL determinants are situated on molecules different from H-2. Evidently the 
TL product is not itself the C fraction 280 m/z absorbance peak but is closer to 
this than to the H-2 fraction. Thus the TL product cannot be homogeneous and 
it may be significant that  the corresponding fraction from TL--  sources has 
shown two bands on polyacrylamide gel electrophoresis (7) ; it is not yet known 
whether  a  TL analogue  is  present  in  TL--  cells.  The  B/C  fraction relative D.  A.  L.  DAVIES~ E.  A.  BOYSE, L.  J.  OLD, E.  STOCKERT  557 
activities for TL specificities may be within the margins of error of the test sys- 
tems and should not be taken to indicate that TL.  1,  TL.  2,  and TL. 3  are 
separable. 
It is too soon to speculate on the chemical relationship between H-2 and TL 
antigens; although they are dearly separable they are presumably somewhat 
similar. The possibility that one is derived by modification of the other is not 
ruled out but would require that all H-2 specificifies  are eliminated in the deri- 
vation of TL, or vice versa, and on the whole this is unlikely. 
From the viewpoint of tumor immunology, TL is a  model of considerable 
interest as an example of a  tumor-specific antigen arising by activation of an 
ordinarily silent gene. Moreover TL antigen proves to be a  molecular entity 
that can be extracted and purified for further study. Present studies on TL. 1 
antigen from leukemia ceils of TL-- mice will show in what respects this mole- 
cule differs from the TL. 1, 2, 3 complex of TL-k strains. 
SUMMARY 
Mouse H-2 histocompatibility antigen has been extracted, soluffflized,  and 
partly purified from the cells of an A strain spontaneous leukemia carrying TL 
(thymus-leukemia) antigens. H-2 and TL. 1, 2, 3 activities were measured by 
inhibition of the cytotoxic effect of the corresponding isoantibodies. 
TL activity was associated with the H-2 active fraction obtained by solubil- 
ization and fractionation by gel filtration. TL specificity was largely separated 
from H-2 antigen by subsequent chromatography on DEAE Sephadex as an 
adjacent component in a series of fractious. 
The soluble H-2 antigen prepared from the leukemia cells was tested for most 
of the specificities determined by H-2  ~ with no exceptional results. 
TL. 1, 2, 3 activities, measured as each component separately, were located in 
approximately the same position; there is no clear indication yet whether the 
three TL specificities  are separable from one another. 
It appears that in addition to the close genetic linkage between the H-2 and 
TL loci, and their reciprocal interaction in producing H-2  and TL antigens, 
these antigens exhibit some similarity at the chemical level. 
We thank Mr. A. J. Manstone, Mr. V. S. G. Baugh, and Miss Barbara J. Alkins  for excellent 
assistance. 
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